Description

Morpholine, 4-[[(3-Chloro-7,8,9,10-Tetrahydro-6-Phenanthridinyl)Thio]Acetyl]- (9Ci) is a specialized morpholine derivative and a high-purity synthetic intermediate of significant interest in advanced organic synthesis. Its molecular architecture, featuring a phenanthridine core linked via a thioacetyl bridge, makes it a valuable building block for constructing complex heterocyclic systems. This compound is primarily sought by research institutions and pharmaceutical R&D departments for the development of novel active pharmaceutical ingredients (APIs) and other fine chemicals.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly those targeting neurological or oncological pathways.
• Organic Synthesis Building Block: Used in research-scale reactions to construct complex polycyclic and heterocyclic molecular frameworks.
• Agrochemical Research: Serves as a starting material for developing new active ingredients for crop protection products.
• Material Science Research: Investigated for the creation of specialty polymers or organic electronic materials with specific functionalities.
• Chemical Biology Probe Development: Utilized in the design and synthesis of molecular probes for studying biological processes and target validation.

Basic Information

Product Name	Morpholine, 4-[[(3-Chloro-7,8,9,10-Tetrahydro-6-Phenanthridinyl)Thio]Acetyl]- (9Ci)
CAS No.	606108-79-6
Molecular Formula	C21H21ClN2O2S
Molecular Weight	400.92 g/mol
Synonyms	4-[[(3-Chloro-7,8,9,10-tetrahydro-6-phenanthridinyl)thio]acetyl]morpholine; 4-[(3-Chloro-6,7,8,9-tetrahydro-5H-phenanthridin-10-yl)sulfanyl]acetyl]morpholine; N-[(3-Chloro-7,8,9,10-tetrahydro-6-phenanthridinyl)thioacetyl]morpholine; 606108-79-6; 4-({2-[(3-Chloro-5,6,7,8-tetrahydro-9-phenanthridinyl)thio]acetyl})morpholine (alternative IUPAC).
EINECS	Contact for details

Quality Control

Our production of Morpholine, 4-[[(3-Chloro-7,8,9,10-Tetrahydro-6-Phenanthridinyl)Thio]Acetyl]- (9Ci) adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity, critical for research and development applications. Each lot is supported by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles, typically determined by advanced analytical techniques such as HPLC, NMR, and mass spectrometry. We operate in compliance with cGMP guidelines where applicable for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). The compound may be light-sensitive and should be handled under an inert atmosphere if found to be easily oxidized. Keep away from strong acids, bases, and oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.